Solventum Corporation (SOLV)
| Market Cap | 12.70B |
| Revenue (ttm) | 8.22B |
| Net Income (ttm) | 720.00M |
| Shares Out | 172.75M |
| EPS (ttm) | 4.16 |
| PE Ratio | 17.66 |
| Forward PE | 13.66 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,395,797 |
| Open | 73.10 |
| Previous Close | 72.69 |
| Day's Range | 71.95 - 73.67 |
| 52-Week Range | 47.16 - 77.17 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 68.29 (-7.1%) |
| Earnings Date | Jan 28, 2025 |
About SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a c... [Read more]
Financial Performance
In 2023, Solventum's revenue was $8.20 billion, an increase of 0.82% compared to the previous year's $8.13 billion. Earnings were $1.35 billion, an increase of 0.22%.
Financial numbers in USD Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price forecast is $68.29, which is a decrease of -7.10% from the latest price.
News
Peltz's Trian Fund says 3M's Solventum spin-off not living up to potential
Nelson Peltz's Trian Fund Management said in a letter to shareholders on Wednesday that medical device maker Solventum's separation from 3M has not been living up to its potential.
Trian Issues Open Letter to Solventum Shareholders
Despite Performance Declines Since Spinning Out of 3M, Trian Believes Solventum Has Potential to Drive Significant Improvements as a Standalone Company
The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing
Former Bristol Myers Squibb, Goldman Sachs, and Barclays executive brings deep expertise in corporate strategy, partnership development, public and private financial markets, and management as the org...
Solventum to Participate in the Piper Sandler Healthcare Conference
ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on ...
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn.
Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript
Solventum Corporation (NYSE:SOLV) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kevin Moran - SVP, IR Bryan Hanson - CEO Wayde McMillan - CFO Conference Call Parti...
Solventum raises annual profit forecast on strong surgical product sales
3M spin-off Solventum raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free cash f...
Solventum Taps Bankers to Explore Sale of Filtration Unit
The business is expected to draw takeover interest from private equity and strategic buyers.
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
ST. PAUL, Minn. , Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close.
Solventum Announces Commitment to 100% Renewable Electricity by 2030
ST. PAUL, Minn. , Oct. 14, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030.
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
ST. PAUL, Minn. , Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer.
Buy 4 October Dividend Aristocrats & Watch 10
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024...
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy
New V.A.C.® Peel and Place Dressing makes negative pressure wound therapy more accessible, less painful ST. PAUL, Minn.
Solventum to Participate in Upcoming Investor Conferences
ST. PAUL, Minn. , Aug. 28, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on We...
Lanny's Stock Sales Through June 30, 2024
I sold Chimera. They were an underperforming REIT, even on their best days. I actually have received total proceeds of $10,967 and have recognized a total gain of $1,090.40. Warner Bro. Discovery, as ...
Trade Tracker: Jenny Harrington sells Solventum Corp.
Jenny Harrington, CEO Gilman Hill Asset Management, joins CNBC's "Halftime Report" to explain why she's getting out of Solventum.
Solventum autonomous coding listed in Epic Toolbox
ST. PAUL, Minn., Aug. 20, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced that its autonomous coding solution has received Toolbox designation from Epic in the Fu...
Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript
Solventum Corporation (NYSE:SOLV) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer W...
Solventum's second-quarter profit falls 70% on higher expenses
3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates fu...
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance
Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Gene...
Curreen Capital: Ugly Ducklings Selling At An Attractive Price
We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through...
Activist Trian has a few levers to pull to build shareholder value at Solventum
Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market.
Solventum Stock Jumps as Activist Trian Discloses Stake
The move comes just months after 3M spun off the healthcare product company.